| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients
|
QUILICI, S.
|
|
2006
|
60 |
8 |
p. 922-932
|
artikel
|
| 2 |
A double-blind randomised trial to evaluate the effect of anastrozole for the treatment of non-toxic multinodular goitre
|
KNIGHT, J. S.
|
|
2006
|
60 |
8 |
p. 911-913
|
artikel
|
| 3 |
A reply: Ethics and Pharmaceutical Medicine
|
Paterson, K. R.
|
|
2006
|
60 |
8 |
p. 1009
|
artikel
|
| 4 |
Baclofen: a new drug for the treatment of alcohol dependence
|
ADDOLORATO, G.
|
|
2006
|
60 |
8 |
p. 1003-1008
|
artikel
|
| 5 |
CATIE for clinicians
|
Kerwin, R.
|
|
2006
|
60 |
8 |
p. 892-893
|
artikel
|
| 6 |
Comparison of phosphodiesterase type 5 (PDE5) inhibitors
|
WRIGHT, P. J.
|
|
2006
|
60 |
8 |
p. 967-975
|
artikel
|
| 7 |
Effect of orlistat in overweight poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study
|
KUO, C-S
|
|
2006
|
60 |
8 |
p. 906-910
|
artikel
|
| 8 |
Efficacy, safety and LDL-C goal attainment of ezetimibe 10 mg–simvastatin 20 mg vs. placebo–simvastatin 20 mg in UK-based adults with coronary heart disease and hypercholesterolaemia
|
PATEL, J. V.
|
|
2006
|
60 |
8 |
p. 914-921
|
artikel
|
| 9 |
Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care
|
ODEYEMI, I. A. O.
|
|
2006
|
60 |
8 |
p. 949-958
|
artikel
|
| 10 |
Management of advanced chronic kidney disease in primary care – current data from Germany
|
HERGET-ROSENTHAL, S.
|
|
2006
|
60 |
8 |
p. 941-948
|
artikel
|
| 11 |
Management of advanced HIV disease in patients with tuberculosis or hepatitis co-infection
|
NELSON, M.
|
|
2006
|
60 |
8 |
p. 976-983
|
artikel
|
| 12 |
Measuring the impact of childhood atopic dermatitis
|
Graham-Brown, R.
|
|
2006
|
60 |
8 |
p. 895
|
artikel
|
| 13 |
Metabolic approach to heart failure – evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis
|
Jackson, Graham
|
|
2006
|
60 |
8 |
p. 891-892
|
artikel
|
| 14 |
PDE-5 inhibitors: spoilt for choice
|
Kirby, M. G.
|
|
2006
|
60 |
8 |
p. 893-894
|
artikel
|
| 15 |
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors
|
MALININ, A. I.
|
|
2006
|
60 |
8 |
p. 993-1002
|
artikel
|
| 16 |
Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema
|
LEWIS-JONES, S.
|
|
2006
|
60 |
8 |
p. 984-992
|
artikel
|
| 17 |
Response to: Angiotensin receptor blockers in hypertension: the emerging role in diabetes mellitus
|
Varughese, G. I.
|
|
2006
|
60 |
8 |
p. 1010-1012
|
artikel
|
| 18 |
Response to: Ethics, data and the pharmaceutical physician
|
Dayan, A. D.
|
|
2006
|
60 |
8 |
p. 1009
|
artikel
|
| 19 |
Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study
|
RIZZOLI, R.
|
|
2006
|
60 |
8 |
p. 1013-1019
|
artikel
|
| 20 |
Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
|
CITROME, L.
|
|
2006
|
60 |
8 |
p. 933-940
|
artikel
|
| 21 |
Solifenacin significantly improves all symptoms of overactive bladder syndrome
|
CHAPPLE, C. R.
|
|
2006
|
60 |
8 |
p. 959-966
|
artikel
|
| 22 |
Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study *
|
COOPER, A.
|
|
2006
|
60 |
8 |
p. 896-905
|
artikel
|
Tijdschrift beschrijving